Composition
- Active ingredients
- RIFAMPIN 600MG/VIAL
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- RIFAMPIN 600MG/VIAL · InjectableANDA204101-001 · Discontinued
- RIFAMPIN 600MG/VIAL · InjectableANDA205039-001 · Prescription
- RIFAMPIN 600MG/VIAL · InjectableANDA065502-001 · Prescription
- RIFAMPIN 600MG/VIAL · InjectableANDA064217-001 · Prescription
- RIFAMPIN 300MG · CapsuleANDA065028-002 · Discontinued
- RIFAMPIN 150MG · CapsuleANDA065028-001 · Discontinued
- RIFAMPIN 600MG/VIAL · InjectableANDA065421-001 · Prescription
- RIFAMPIN 600MG/VIAL · InjectableThis page
- RIFAMPIN 300MG · CapsuleANDA064150-001 · Prescription
- RIFAMPIN 150MG · CapsuleANDA064150-002 · Prescription
- RIFAMPIN 600MG/VIAL · InjectableANDA091181-001 · Prescription
- RIFAMPIN 300MG · CapsuleANDA065390-002 · Prescription
- RIFAMPIN 150MG · CapsuleANDA065390-001 · Prescription
- RIFAMPIN 300MG · CapsuleANDA090034-002 · Prescription
At a glance
- Brand name
- Rifampin
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Watson Pharms Teva
- Status
- Discontinued
- FDA approval
- 19 Jan 2016
- Application
- ANDA206736-001